dc.creatorArruda, J. C. C.
dc.creatorRocha, N. C.
dc.creatorSantos, E. G.
dc.creatorFerreira, L. G. B.
dc.creatorBello, M. L.
dc.creatorPenido, C.
dc.creatorCosta, T. E. M. M.
dc.creatorSantos, J. A. A.
dc.creatorRibeiro, I. M.
dc.creatorTomassini, T. C. B.
dc.creatorFaria, R. X.
dc.date2021-12-11T14:44:12Z
dc.date2021-12-11T14:44:12Z
dc.date2021
dc.date.accessioned2023-09-26T22:21:41Z
dc.date.available2023-09-26T22:21:41Z
dc.identifierARRUDA, J. C. C. et al. Physalin pool from Physalis angulata L. leaves and physalin D inhibit P2X7 receptor function in vitro and acute lung injury in vivo. Biomedicine & Pharmacotherapy, v. 142, 112006, p. 1 - 19, Aug. 2021.
dc.identifier0753-3322
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/50310
dc.identifier10.1016/j.biopha.2021.112006
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8878308
dc.descriptionP2X7 receptor promotes inflammatory response and neuropathic pain. New drugs capable of impairing inflammation and pain-reducing adverse effects extracted from plant extracts have been studied. Physalis angulate L. possesses traditional uses and exhibits antiparasitic, anti-inflammatory, antimicrobial, antinociceptive, antimalarial, antileishmanial, immunosuppressive, antiasthmatic. diuretic, and antitumor activities. The most representative phytochemical constituents identified with medicinal importance are the physalins and withanolides. However, the mechanism of anti-inflammatory action is scarce. Although some physalins and withanolides subtypes have anti-inflammatory activity, only four physalins subtypes (B, D, F, and G) have further studies. Therefore, we evaluated the crude ethanolic extract enriched with physalins B, D, F, and G from P. angulata leaves, a pool containing the physalins B, D, F, G, and the physalins individually, as P2X7 receptor antagonists. For this purpose, we evaluated ATP-induced dye uptake, macroscopic currents, and interleukin 1-β (IL-1β) in vitro. The crude extract and pool dose-dependently inhibited P2X7 receptor function. Thus, physalin B, D, F, and G individually evaluated for 5′ -triphosphate (ATP)-induced dye uptake assay, whole-cell patch-clamp, and cytokine release showed distinct antagonist levels. Physalin D displayed higher potency and efficacy than physalin B, F, and G for all these parameters. In vivo mice model as ATP-induced paw edema was potently inhibited for physalin D, in contrast to physalin B, F, and G. ATP and lipopolysaccharide (LPS)-induced pleurisy in mice were reversed for physalin D treatment. Molecular modeling and computational simulation predicted the intermolecular interactions between the P2X7 receptor and physalin derivatives. In silico results indicated physalin D and F as a potent allosteric P2X7 receptor antagonist. These data confirm physalin D as a promisor source for developing a new P2X7 receptor antagonist with anti-inflammatory action.
dc.formatapplication/pdf
dc.languageeng
dc.publisherElsevier
dc.rightsopen access
dc.subjectAnti-inflamatório
dc.subjectPulmão
dc.subjectPré-clínico
dc.subjectReceptores purinérgicos
dc.subjectFormação de poros
dc.subjectProdutos naturais
dc.subjectAnti-inflammatory
dc.subjectAnti-inflamatório
dc.subjectPre-clinical
dc.subjectPurinergic receptors
dc.subjectPore formation
dc.subjectNatural products
dc.titlePhysalin pool from Physalis angulata L. leaves and physalin D inhibit P2X7 receptor function in vitro and acute lung injury in vivo
dc.typeArticle


Este ítem pertenece a la siguiente institución